Efficacy and tolerability of eperisone and baclofen in spastic palsy: A double-blind randomized trial

Advances in Therapy

Volumn 26, Issue 5, 2009, Pages 563-573

  Bresolin, N ^a   Zucca, C ^b   Pecori, A ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

^c Medical Department Eisai Srl   (Italy)

Author keywords

Baclofen; Central muscle relaxants; Double blind; Eperisone; Randomized; Spastic palsy

Indexed keywords

BACLOFEN; EPERISONE;

10 METER WALKING TIME; ADULT; AMENORRHEA; ANOREXIA; ARTICLE; ASTHENIA; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ECZEMA; ELECTROMYOGRAPHY; EPIGASTRIC PAIN; FEMALE; FUNCTIONAL STATUS; HEAT SENSATION; HMAX MMAX AMPLITUDE RATIO; HUMAN; HYPERTENSION; INSOMNIA; ISCHIALGIA; JOINT CHARACTERISTICS AND FUNCTIONS; LEG HYPOASTHENIA; LEUKOCYTOSIS; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; MUSCLE HYPOTONIA; MUSCLE REFLEX; MUSCLE TONE; NAUSEA; PARESTHESIA; PEDERSEN SCALE; PHASE 3 CLINICAL TRIAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SHIVERING; SIDE EFFECT; SOMNOLENCE; SPASTIC PARESIS; SWEATING; UPPER ABDOMINAL PAIN; VERTIGO; WARTENBERG TEST;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; BACLOFEN; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; PROPIOPHENONES; RANGE OF MOTION, ARTICULAR; REFLEX; REFLEX, ABNORMAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WALKING;

EID: 73449095462     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0031-8     Document Type: Article

References (28)

1. I. Dones 2007 Intrathecal baclofen for the treatment of spasticity Acta Neurochir Suppl 97 185 188 17691375 10.1007/978-3-211-33079-1-25 1:STN:280:DC%2BD2svntl2ntg%3D%3D
2. M. Saulino B.W. Jacobs 2006 The pharmacological management of spasticity J Neurosci Nurs 38 456 459 17233517
3. P.M. Brennan I.R. Whittle 2008 Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain Br J Neurosurg 22 508 519 18649160 10.1080/02688690802233364 1:STN:280: DC%2BD1cnhsVGqsw%3D%3D
4. J.S. Rietman J.H. Geertzen 2007 Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome Acta Neurochir Suppl 97 205 211 17691378 10.1007/978-3-211-33079-1-28 1:STN:280:DC%2BD2svntl2ntQ%3D%3D
5. P.W. Nance 1994 A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients J Am Paraplegia Soc 17 150 156 7964712 1:STN:280:DyaK2M%2FlsVSjtA%3D%3D
6. B. Bass B. Weinshenker G.P. Rice 1988 Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis Can J Neurol Sci 15 15 19 3345456 1:STN:280:DyaL1c7ltVKjtw%3D%3D
7. K. Bose 1999 The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial Methods Find Exp Clin Pharmacol 21 209 213 10389124 10.1358/mf.1999.21.3. 534831 1:CAS:528:DyaK1MXktVeiur8%3D (Pubitemid 29262305)
8. P. Cabitza P. Randelli 2008 Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study Eur Rev Med Pharmacol Sci 12 229 235 18727454 1:STN:280:DC%2BD1crksFWntQ%3D%3D
9. A. Beltrame S. Grangiè L. Guerra 2008 Clinical experience with eperisone in the treatment of acute low back pain Minerva Med 99 347 352 18663343 1:STN:280:DC%2BD1cvotlWjtw%3D%3D
10. S. Sartini L. Guerra 2008 Open experience with a new myorelaxant agent for low back pain Adv Ther 25 1010 1018 18836866 10.1007/s12325-008-0108-9 1:CAS:528:DC%2BD1MXmtVejtw%3D%3D
11. E. Rodriguez Boronat F. Colomer Rusinyol F. Ferrer Bosch R. Viladot Pericé 2008 Myorelaxant effects of eperisone and diazepam in the treatment of acute spinal muscle contracture: a comparative study J Anaesthesiol Clin Pharmacol 24 285 290
12. K. Tanaka T. Kaneko K. Yamatsu 1981 Effects of 4′-ethyl-2-methyl-3- piperidinopropiophenone on experimental contracture and spinal cord activities [in Japanese] Folia Pharmcol Jpn 77 511 520 10.1254/fpj.77.511 1:CAS:528:DyaL3MXktlGntb8%3D
13. T. Mano T. Miyaoka 1981 Effects of muscle relaxant E.M.P.P. on afferent discharges of muscle spindle in man - an microneurographic analysis [in Japanese] No To Shinkei 33 237 241 6454427 1:STN:280:DyaL3M3jt1Ggsw%3D%3D
14. C. Grassi M. Passatore 1990 Spontaneous sympathetic command to skeletal muscles; functional implications Funct Neurol 5 227 232 2149355 1:STN:280:DyaK3M7jtFSgtg%3D%3D
15. S. Iwase T. Mano M. Saito G. Ishida 1992 Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans Funct Neurol 7 459 470 1338431 1:STN:280:DyaK3s3hs1WmsA%3D%3D
16. Y. Sakai Y. Matsuyama H. Nakamura 2008 The effect of muscle relaxant on the paraspinal muscle blood flow: a randomized controlled trial in patients with chronic low back pain Spine 33 581 587 18344850 10.1097/BRS.0b013e318166e051
17. M. Ishizuki M. Yanagisawa 1992 Antinociceptive effects of tizanidine, diazepam and eperisone in isolated spinal cord-tail preparations of newborn rat Pain 48 101 106 1482424 10.1016/0304-3959(92)90136-Y 1:CAS:528: DyaK38XpvFahtA%3D%3D
18. Bresolin N, Zucca C, Pecori A. Efficacy and tolerability of eperisone in patients with spastic palsy: a cross-over, placebo-controlled dose-ranging trial. PECONIC. Eur Rev Med Pharmacological Sci. 2009. In press.
19. A.D. Pandyan G.R. Johnson C.I. Price R.H. Curless M.P. Barnes H. Rodgers 1999 A review of the properties and limitations of the Ashworth and modified Ashworth scales as measures of spasticity Clin Rehabil 13 373 383 10498344 10.1191/026921599677595404 1:STN:280:DyaK1Mvis1Kmug%3D%3D (Pubitemid 29425632)
20. Russell DJ, Rosenbaum PL, Avery LM, Lane M. Gross Motor Function Measure (GMFM-66 & GMFM-88) User's Manual. London: Mac Keith Press; 2002.
21. M. Tariq N. Akhtar M. Ali S. Rao M. Badshah M. Irshad 2005 Eperisone compared to physiotherapy on muscular tone of stroke patients: a prospective randomized open study J Pak Med Assoc 55 202 204 15960286
22. Pedersen E. Spasticity: Mechanism, Measurement, Management. Springfield, IL: Charles C. Thomas; 1969.
23. J.T. Hsieh D.L. Wolfe W.C. Miller A. Curt 2008 SCIRE Research Team. Spasticity outcome measures in spinal cord injury: psychometric properties and clinical utility Spinal Cord. 46 86 95 17909559 10.1038/sj.sc.3102125 1:STN:280:DC%2BD1c7msVaitw%3D%3D (Pubitemid 351227340)
24. R.A. Macdonell A. Talalla M. Swash D. Grundy 1989 Intrathecal baclofen and the H-reflex J Neurol Neurosurg Psychiatry 52 1110 1112 2795085 10.1136/jnnp.52.9.1110 1:STN:280:DyaK3c%2FhtFWnug%3D%3D
25. A. Dario G. Tomei 2004 A benefit-risk assessment of baclofen in severe spinal spasticity Drug Saf 27 799 818 15350152 10.2165/00002018-200427110-00004 1:CAS:528:DC%2BD2cXosl2gsb4%3D (Pubitemid 39243562)
26. M.A. Hoving E.P. van Raak G.H. Spincemaille L.J. Palmans F.A. Sleypen J.S. Vles 2007 Dutch Study Group on Child Spasticity. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study Dev Med Child Neurol. 49 654 659 17718820 10.1111/j.1469-8749.2007.00654.x (Pubitemid 47316786)
27. P. Van Schaeybroeck B. Nuttin L. Lagae E. Schrijvers C. Borghgraef P. Feys 2000 Intrathecal baclofen for intractable cerebral spasticity: a prospective placebocontrolled, double-blind study Neurosurgery 46 603 609 10719857 10.1097/00006123-200003000-00017
28. F. Biering-Sørensen J.B. Nielsen K. Klinge 2006 Spasticity assessment: a review Spinal Cord 44 708 722 16636687 10.1038/sj.sc.3101928 (Pubitemid 44934977)